ENDLOS-TURBO CALL - ELI LILLY & CO | Market Closed - Deutsche Boerse AG 15:34:35 2024-06-25 EDT | ||
| 53.53 EUR | +1.90% |
|
| Current month | +18.85% | ||
| 1 month | +20.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 53.53 | +1.90% |
| 24-06-24 | 52.53 | +0.98% |
| 24-06-21 | 52.02 | +0.44% |
| 24-06-20 | 51.79 | -1.71% |
| 24-06-19 | 52.69 | +0.82% |
Delayed Quote Deutsche Boerse AG
Last update June 25, 2024 at 03:34 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | DZ BANK |
| WKN | DDZ98W |
| ISIN | DE000DDZ98W8 |
| Date issued | 2023-03-09 |
| Strike | 328.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.33 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 54.12 € |
|---|---|
| Lowest since issue | 1.09 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
904.6
USD
Average target price
860.5
USD
Spread / Average Target
-4.87%
- Stock Market
- Certificates
- Certificat
